Metformin Aurobindo

Metformin Hydrochloride, the active ingredient in Metformin Aurobindo, is a biguanide presented as an oral tablet for oral use. It is used to improve glycaemic control in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Aurobindo belongs to the biguanide class and is employed in the management of disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels and helps achieve target HbA1c. - Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when combined with lifestyle modification. - Polycystic ovary syndrome (off‑label in some regions): may improve insulin resistance and menstrual regularity.

Metformin Aurobindo may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: watery stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Decreased appetite: reduced desire to eat. - Vitamin B12 deficiency: long‑term use may lower levels.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycaemia: usually when combined with insulin or sulfonylureas. - Hepatic failure: worsening liver function may precipitate toxicity. - Allergic reactions: rash, pruritus, or angio‑edema. - Myopathy: muscle pain or weakness in rare cases. - Electrolyte disturbances: especially with dehydration.

Metformin Aurobindo requires careful patient assessment and monitoring. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function: evaluate liver enzymes to reduce risk of lactic acidosis. - Cardiovascular status: avoid in patients with unstable or acute heart failure. - Elderly patients: start at lower doses and monitor for accumulation. - Concomitant alcohol use: limit intake to minimise lactic acidosis risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Aurobindo can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol excess: enhances risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics (especially thiazides): can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function when combined. - Warfarin: may require INR monitoring. - Antiretroviral agents (e.g., protease inhibitors): may increase metformin levels.